Stocks and InvestingStocks and Investing
Wed, January 8, 2020
Tue, January 7, 2020
Mon, January 6, 2020
Fri, January 3, 2020
Thu, January 2, 2020
Tue, December 31, 2019
Mon, December 30, 2019

David Amsellem Maintained (BHC) at Buy with Increased Target to $39 on, Dec 30th, 2019


Published on 2024-10-26 19:32:07 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Maintained "Bausch Health Companies Inc." (BHC) at Buy with Increased Target from $30 to $39 on, Dec 30th, 2019.

David has made no other calls on BHC in the last 4 months.



There are 2 other peers that have a rating on BHC. Out of the 2 peers that are also analyzing BHC, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Chris Schott of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $38 on, Thursday, December 12th, 2019
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $60 on, Monday, December 2nd, 2019